The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of anti-EGFR-based treatment (tx) in second-line and beyond according to tumor location (TL) in RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts): A mono-institutional retrospective analysis.
 
Raffaella Vivolo
No Relationships to Disclose
 
Maria Alessandra Calegari
No Relationships to Disclose
 
Michele Basso
No Relationships to Disclose
 
Ina Valeria Zurlo
No Relationships to Disclose
 
Brunella Di Stefano
No Relationships to Disclose
 
Maria Bensi
No Relationships to Disclose
 
Floriana Camarda
No Relationships to Disclose
 
Maurizio Martini
No Relationships to Disclose
 
Alessandra Cocomazzi
No Relationships to Disclose
 
Carmelo Pozzo
Consulting or Advisory Role - Amgen; Merck Serono; Sanofi/Aventis; SERVIER
Speakers' Bureau - SERVIER
Travel, Accommodations, Expenses - Amgen; Roche; SERVIER
 
Emilio Bria
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Helsinn Healthcare; Lilly; MSD Oncology; Novartis; Pfizer; Roche (Inst)
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Lisa Salvatore
Honoraria - Bayer; Merck Serono; Roche; SERVIER
Consulting or Advisory Role - Bayer; Merck Serono; SERVIER
Travel, Accommodations, Expenses - Bayer; Merck Serono; Sanofi
 
Giampaolo Tortora
Consulting or Advisory Role - Celgene; Merck Serono
Travel, Accommodations, Expenses - Merck Serono; Roche